The wider implication of possible under reporting of BRCA1 Exon 13 duplication can be seen in two recent publications in which only one case of this large rearrangement was reported in over 22,000 ovarian cancer tissue samples tested using the myChoice® CDx [33,34]. The gene discussed is BRCA1; the disease is ovarian cancer.